文献速递神经MR

欧洲神经科与放射科医生对ARIA监测准备度的调查

Are we ready for amyloid-related imaging abnormalities (ARIA) monitoring? A European survey among neuroradiologists and neurologists by the ESNR/EAN Working Group.
PubMed 文献 · Eur Radiol · 2026-01-06

ESNR/EAN ARIA工作组对41个欧洲国家的422名神经科和(神经)放射科医生进行在线调查,评估其对淀粉样蛋白相关影像异常(ARIA)的认知与监测准备情况。结果显示69%受访者熟悉ARIA概念,82%缺乏专用ARIA成像方案,93%希望接受进一步培训。

要点

  • 82%受访者缺乏专用ARIA成像方案,阅片报告需注意ARIA-E与ARIA-H的系统评估
  • 对ARIA-H的判断信心为69%,略高于对ARIA-E的60%,放射科医生信心高于神经科医生
  • 93%希望获得ARIA监测的进一步培训,提示当前临床培训存在明显缺口

核心结论

  • 欧洲神经科和(神经)放射科医生对ARIA有一定认知,但实际准备和培训存在明确缺口
  • 82%缺乏专用ARIA成像方案,34%感觉难以满足后勤需求,93%希望接受进一步培训

研究设计与样本

  • 在线问卷调查,共32个条目,包含多选、单选和自由文本形式
  • 2024年6月至7月间收集41个欧洲国家422份回复,47%为神经科医生,51%为(神经)放射科医生
  • 15%为住院医师,58%在学术型医院工作

关键影像表现/征象

  • 60%受访者报告能够理解ARIA的风险因素
  • 对ARIA-E(水肿/积液)亚型评估的信心为60%,对ARIA-H(出血)亚型为69%
  • 关键障碍包括组织适应能力有限和放射科专业经验不足

诊断标准与关键数值

  • 69%受访者熟悉ARIA概念
  • 72%认为人工智能方法有潜在辅助价值
  • 93%表达希望获得ARIA监测进一步培训的意愿

临床应用与阅片要点

  • 日常阅片时需分别评估ARIA-E(水肿/积液)与ARIA-H(出血)亚型,报告中应明确区分
  • 缺乏专用ARIA成像方案时,需警惕扫描序列不一致对ARIA判读的影响
  • 神经科与放射科医生对ARIA判读信心存在差异,依赖于多学科协作
  • 当前临床部门需加强组织适应能力和放射科ARIA判读经验储备

局限性

  • 调查基于自我报告,未通过实际图像判读测试验证能力
  • 缺乏受访者所在机构实际开展淀粉样蛋白相关免疫治疗的信息

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Amyloid-lowering immunotherapies can cause amyloid-related imaging abnormalities (ARIA), requiring brain MRI for detection and monitoring. The European Society of Neuroradiology (ESNR)/European Academy of Neurology (EAN) ARIA Working Group conducted a survey to assess European clinicians' readiness for this logistical challenge and need for further education on ARIA.

MATERIALS AND METHODS: An online questionnaire with 32 items (multiple choice, single best choice, and free text) was distributed to ESNR and EAN members. Between June and July 2024, we collected 422 responses from 41 European countries, including 47% neurologists and 51% (neuro)radiologists; 15% were residents, and 58% worked in academic hospitals.

RESULTS: Of respondents, 69% were familiar with the concept of ARIA, and 60% reportedly understood its risk factors. Confidence in evaluating ARIA-E (edema/effusion) and ARIA-H (hemorrhage) subtypes was reported by 60% and 69%, respectively, with (neuro)radiologists more confident than neurologists. However, 34% of respondents felt poorly equipped to meet logistical demands, and 82% lacked a dedicated ARIA imaging protocol. Key barriers included limited organizational adaptability and radiology expertise. Notably, 72% saw potential in having support by artificial intelligence approaches, and 93% expressed the wish for further training on how to monitor ARIA.

CONCLUSIONS: Despite the current unavailability of amyloid-lowering therapies, European neurologists and (neuro)radiologists report reasonable ARIA awareness. There is a clear need for additional practical preparation and training in ARIA assessment, which can inform future ESNR/EAN educational initiatives.

KEY POINTS: Question Are neurologists and neuroradiologists ready for ARIA monitoring? Findings Neurologists and neuroradiologists were moderately familiar with the concept of ARIA, its risk factors, and its identification on MRI, but felt poorly equipped to meet the logistical demands. Clinical relevance With the potential introduction of amyloid-lowering therapies in European countries, identifying key barriers, such as limited organizational adaptability and radiology expertise, highlights the need for further practical preparation by clinical departments and additional training in ARIA assessment.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Oliveira, Vernooij, Frisoni, et al. Are we ready for amyloid-related imaging abnormalities (ARIA) monitoring? A European survey among neuroradiologists and neurologists by the ESNR/EAN Working Group. Eur Radiol. 2026. PMID: 41493545. doi:10.1007/s00330-025-12214-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。